COLLAGEN AESTHETICS INC

Collagen Aesthetics Inc. develops collagen-centric dermal scaffolding, regenerative topical therapies, and implementation support that help med-spa operators, cosmetic dermatologists, and specialty surgery centers expand aesthetic portfolios, and the firm positions itself at the intersection of the SIC 80-series health services and the cosmetic-supply wholesale classifications where advanced skin-rejuvenation consumables and clinical training converge. Its core services reach beyond product sales to include technique coaching and compliance guidance, reflecting the capital-light commercialization path of companies that lean on physician partners rather than retail consumers. This strategy keeps the business proximate to SIC 5999 wholesalers while leaning on the clinical rigor of SIC 2844 and SIC 3845 adjacent specialties, yet it also highlights persistent material risks: the need for FDA or equivalent agency clearances for new formulations, vigilance around adverse events, strict quality audits in outsourced manufacturing, and exposure to shifting reimbursement or liability climates that affect any emerging device/biologic play. Latest filings remain pending, and investors can watch for updates—View live SEC filings on Earnings Feed.

Source: Earnings Feed research · last updated 11/24/2025